Total Payments
$43,727
2023 Payments
$10,450
Companies
4
Transactions
26
Medicare Patients
1,031
Medicare Billing
$87,630
Payment Breakdown by Category
Consulting$37,866 (86.6%)
Other$4,760 (10.9%)
Travel$874.47 (2.0%)
Food & Beverage$225.93 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,866 | 14 | 86.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,760 | 5 | 10.9% |
| Travel and Lodging | $874.47 | 4 | 2.0% |
| Food and Beverage | $225.93 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $37,646 | 18 | $0 (2023) |
| Allergan Inc. | $3,000 | 6 | $0 (2019) |
| Merck KGaA | $2,960 | 1 | $0 (2021) |
| Corcept Therapeutics | $121.06 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $10,450 | 2 | ABBVIE INC. ($10,450) |
| 2022 | $17,400 | 4 | ABBVIE INC. ($17,400) |
| 2021 | $2,960 | 1 | Merck KGaA ($2,960) |
| 2019 | $8,329 | 12 | AbbVie, Inc. ($7,129) |
| 2018 | $800.00 | 2 | Allergan Inc. ($800.00) |
| 2017 | $3,787 | 5 | AbbVie, Inc. ($2,666) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2023 | ABBVIE INC. | SYNTHROID (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2023 | ABBVIE INC. | SYNTHROID (Drug) | Consulting Fee | Cash or cash equivalent | $8,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2022 | ABBVIE INC. | ARMOUR THYROID (Drug) | Consulting Fee | Cash or cash equivalent | $2,887.50 | General |
| Category: THYROID | ||||||
| 06/14/2022 | ABBVIE INC. | ARMOUR THYROID (Drug) | Consulting Fee | Cash or cash equivalent | $2,612.50 | General |
| Category: THYROID | ||||||
| 03/02/2022 | ABBVIE INC. | SYNTHROID (Drug) | Consulting Fee | Cash or cash equivalent | $6,050.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2022 | ABBVIE INC. | SYNTHROID (Drug) | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2021 | Merck KGaA | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,960.00 | General |
| 11/04/2019 | AbbVie, Inc. | Synthroid (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Endocrinology | ||||||
| 11/04/2019 | AbbVie, Inc. | Synthroid (Drug) | Travel and Lodging | In-kind items and services | $442.53 | General |
| Category: Endocrinology | ||||||
| 11/04/2019 | AbbVie, Inc. | Synthroid (Drug) | Travel and Lodging | In-kind items and services | $282.58 | General |
| Category: Endocrinology | ||||||
| 11/04/2019 | AbbVie, Inc. | Synthroid (Drug) | Travel and Lodging | In-kind items and services | $125.73 | General |
| Category: Endocrinology | ||||||
| 11/04/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Endocrinology | ||||||
| 11/04/2019 | AbbVie, Inc. | Synthroid (Drug) | Travel and Lodging | In-kind items and services | $23.63 | General |
| Category: Endocrinology | ||||||
| 10/02/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $74.98 | General |
| Category: Endocrinology | ||||||
| 08/30/2019 | AbbVie, Inc. | Synthroid (Drug) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: Endocrinology | ||||||
| 05/21/2019 | AbbVie, Inc. | Synthroid (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Endocrinology | ||||||
| 04/25/2019 | Allergan Inc. | — | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| 04/02/2019 | Allergan Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 02/08/2019 | AbbVie, Inc. | Synthroid (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Endocrinology | ||||||
| 11/20/2018 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 02/15/2018 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 11/20/2017 | AbbVie, Inc. | Synthroid (Drug) | Consulting Fee | Cash or cash equivalent | $978.75 | General |
| Category: Endocrinology | ||||||
| 07/18/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 07/18/2017 | Allergan Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 07/12/2017 | AbbVie, Inc. | Synthroid (Drug) | Consulting Fee | Cash or cash equivalent | $1,687.50 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 323 | 367 | $119,364 | $28,203 |
| 2022 | 5 | 249 | 280 | $93,722 | $21,735 |
| 2021 | 5 | 240 | 271 | $85,819 | $21,385 |
| 2020 | 3 | 219 | 254 | $71,227 | $16,307 |
Total Patients
1,031
Total Services
1,172
Medicare Billing
$87,630
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 162 | 199 | $64,874 | $14,894 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 38 | 39 | $18,759 | $4,588 | 24.5% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 17 | 17 | $8,041 | $1,971 | 24.5% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2023 | 26 | 29 | $6,873 | $1,736 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 31 | 31 | $6,851 | $1,693 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $6,244 | $1,389 | 22.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 13 | 13 | $5,447 | $1,353 | 24.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2023 | 22 | 25 | $2,275 | $579.25 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 149 | 173 | $56,398 | $12,879 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 23 | $11,063 | $2,553 | 23.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2022 | 29 | 35 | $8,295 | $1,968 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $6,193 | $1,610 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $6,690 | $1,461 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 23 | $5,083 | $1,265 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 105 | 119 | $38,662 | $9,247 | 23.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 59 | 69 | $19,770 | $5,106 | 25.8% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 18 | 18 | $8,514 | $2,274 | 26.7% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Facility | 2021 | 31 | 38 | $9,006 | $2,190 | 24.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 15 | $7,215 | $1,949 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 12 | $2,652 | $618.93 | 23.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 91 | 110 | $30,839 | $7,023 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 94 | 106 | $27,560 | $6,050 | 22.0% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2020 | 18 | 18 | $8,028 | $2,005 | 25.0% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Facility | 2020 | 16 | 20 | $4,800 | $1,229 | 25.6% |
About Dr. James Hennessey, MD
Dr. James Hennessey, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063459386.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Hennessey, MD has received a total of $43,727 in payments from pharmaceutical and medical device companies, with $10,450 received in 2023. These payments were reported across 26 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($37,866).
As a Medicare-enrolled provider, Hennessey has provided services to 1,031 Medicare beneficiaries, totaling 1,172 services with total Medicare billing of $87,630. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Boston, MA
- Active Since 06/02/2006
- Last Updated 02/17/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1063459386
Products in Payments
- SYNTHROID (Drug) $22,350
- Synthroid (Drug) $9,796
- ARMOUR THYROID (Drug) $5,500
- Korlym (Drug) $121.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Boston
Dr. Jason Gaglia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2.4M
Endocrinology, Diabetes & Metabolism $2.4M
Michael Rosenblatt, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $637,025
Endocrinology, Diabetes & Metabolism $637,025
Dr. Osama Hamdy, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $286,677
Endocrinology, Diabetes & Metabolism $286,677
Augusto Caballero-Robles, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $234,576
Endocrinology, Diabetes & Metabolism $234,576
Martin Abrahamson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $223,325
Endocrinology, Diabetes & Metabolism $223,325
Barbara Kahn, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $197,865
Endocrinology, Diabetes & Metabolism $197,865